|
Legal Times
"One strategy Merck has already employed is a voluntarily recall of Vioxx. In pulling a drug off of the market, rather than being ordered to do so by the Food and Drug Administration, companies retain some command over their image, says Katherine Cahill, leader of the product recall group at Marsh Risk Consulting in New York. That move might ultimately play favorably before juries and help to reduce liability."
|